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Background. For the past eight years, the Kidney Help Trust
of Chennai has run a program to prevent chronic renal failure
by regular screening of an entire population of 25,000, and treat-
ment of diabetes and hypertension with the cheapest available
drugs [1]. The total cost amounts to 25 cents per capita of the
study population.
Methods. The program has recently been expanded to cover
the adjacent area with a population of 21,500. Both the original
population and the new population are being surveyed. Per-
sons at risk of renal failure are identified as reported earlier
[1], and glomerular filtration rate (GFR) is estimated by the
MDRD formula. The survey is as yet incomplete. Six thousand
one hundred people in the new area, and 20,986 in the old, have
been studied so far, and the numbers and percentage of those
with GFR below normal have been compared.
Results. The prevalence of impaired renal function (GFR be-
low 80 mL/min) in the original population is 8.6 per thousand,
and in the new population is 13.9 per thousand (P = 0.005, RR
1.61, CI 1.15–2.24).
Conclusion. This model provides an effective method for pre-
vention of chronic renal failure at the community level.
India is a poor country with a per capita income of
$460/per year. Only 2.2% of the population earns above
$1000 a year, and 29% lie below the poverty line, and
earn less than $100 a year. Against that, the cost of re-
nal transplantation, which is the least expensive way of
treating end-stage renal disease (ESRD), is $6000. It is
clear that India cannot afford renal replacement therapy
for ESRD. In the absence of treatment, the only option
left to the country is prevention.
Approximately 50% of chronic renal failure in India is
due to diabetic nephropathy, hypertensive nephropathy,
or chronic pyelonephritis (Table 1). These can be pre-
vented from going into the end stage by good control of
diabetes and hypertension from the outset, and by find-
ing the cause of urinary infection early and tackling it
effectively. The Kidney Help Trust took up the task of
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preventing chronic renal failure at the community level
with a comprehensive yet cheap screening program, and
treatment with low-cost medicines, hydrochlorothiazide,
reserpine, and hydralazine for hypertension, and gliben-
clamide and metformin for diabetes. The program was set
up in a rural population of approximately 25,000 individ-
uals, and has been described in these pages [1]. The area is
served by a free Primary Health Center (PHC) run by the
government, but people do not use it for chronic ailments
because they need to travel 10 to 15 kilometers to reach
the place, and lose a day’s wages each time they attend the
PHC, which they cannot afford to do. Our program is run
by girls from the villages who are trained and work from
their homes, and visit the patients in their own homes.
A simple questionnaire is used (Table 2), urine is exam-
ined for protein by sulphosalicylic acid, and for glucose
by Benedict’s reagent, and blood pressure is recorded in
all people over the age of five. Our doctor examines those
who test positive on any of these, and we estimate glu-
cose, urea, creatinine, and albumin in all positives. I will
not repeat the details here, except to reiterate that it was
effective (Table 3) at the very low cost of 25 cents per
capita of the population per year.
DOES THE PROGRAM WORK?
There seems little doubt that we have achieved rea-
sonably good control of diabetes, and excellent control
of hypertension, at least among those who cooperated
with us and took their medicines regularly. However, the
primary aim of the project is to prevent chronic renal fail-
ure, and we had to devise a way to find out whether we are
reaching our goal. The most scientific way would be to do
the survey, detect all diseases, and allocate the patients
at random to a treatment and a control group, which we
could follow for 10 years. Denying half the population
treatment is obviously unethical, but a much greater ob-
jection is that we would never obtain the cooperation of
our subjects if we did not treat them all.
We could have retained the results of our original
survey and compared the present situation with that,
but eight years is a long time, and changes in economic
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Table 1. The causes of chronic renal failure at Apollo Hospital
Disease Percentage
Diabetic nephropathy 29.60
Chronic interstitial nephritis 20.39
Chronic glomerulonephritis 17.44
Arteriolar nephrosclerosis 11.00
Chronic pyelonephritis 9.70
Focal and segmental glomerulosclerosis 3.73
Autosomal-dominant polycystic disease 2.32
Obstructive nephropathy 1.86
Percentage of total 96.04
A total of 6420 patients was seen in 17 years. It is possible to do something to
prevent those in bold print, which is 54% of the total.
Table 2. The questionnaire of the Kidney Help Trust
Have you ever had
Frequency: the need to pass urine more than twice in an hour
Dysuria: pain in the urethra, perineum,
or hypogastrium while passing urine
Hematuria or pyuria
Edema or dyspnea
Nocturia
Renal angle pain
Table 3. Results of the domiciliary program of the Kidney Help Trust
Percentage
Cooperated for survey 89.61
Among those diagnosed with disease
Already aware of disease 30.34
Preferred therapy from their own doctors 24.60
Among those who took our therapy
Cooperated for treatment 78.91
Among those who cooperated
Hypertension controlled to 140/90 95.77
Hb A1C reduced to 7% or less 52.13
Hb A1C reduced by 10% or more from original 76.79
circumstances and lifestyle could have occurred, which
would confound the interpretation. We decided that the
best method, though open to criticism, would be to sur-
vey a similar area adjacent to our study group, survey our
own population at the same time, and compare the ef-
fects of our program, now eight years old, with the new
area, which had not had any effort at prevention. This
was rendered easy by the fact that the population in the
villages adjoining our project area had been requesting
of us for some years to extend the project to them. We
were assured of their cooperation.
The initial survey places a greater workload on the Pre-
ventive and Social Health Workers. We sought to mini-
mize it this time by using girls who had finished their
higher secondary school education, and who were await-
ing entrance to the university. We conducted the survey
during their summer vacation. They were given three days
of intensive training, and we added a procedure of ran-
dom checking of their findings to make sure there were
no errors.
Table 4. Age and sex distribution of the original population
Age Male Female Total
<5 1372 1353 2725
6–10 1144 1091 2235
11–15 1080 1042 2122
16–20 1035 1134 2169
21–25 994 1095 2089
26–30 1024 991 2015
31–35 693 727 1420
36–40 680 673 1353
41–45 560 539 1099
46–50 509 503 1012
51–55 350 444 794
56–60 366 447 813
61–65 191 260 451
>65 354 411 765
Total 10352 10710 21062
Table 5. Educational status of the population by age and sex
Age groups Educational status 0–15 16–65 65+ Total
Males
No education 2117 3612 317 6046
Primary 1028 1170 77 2275
Higher sec. 178 1222 31 1431
2+ 5 368 2 375
Diploma 4 47 51
Teachers training 2 3 5
Graduate 143 2 145
Post graduate 24 24
Total 3332 6588 432 10,352
Females
No education 2159 4882 497 7538
Primary 939 1050 30 2019
Higher sec. 147 757 7 911
2+ 7 174 181
Diploma 1 4 5
Teachers training 0
Graduate 54 54
Post graduate 2 2
Total 3253 6923 534 10,710
Both sex
No education 4276 8494 814 13,584
Primary 1967 2220 107 4294
Higher sec. 325 1979 38 2342
2+ 12 542 2 556
Diploma 5 51 56
Teachers training 2 3 5
Graduate 197 2 199
Post graduate 26 26
Total 3332 13511 966 21,062
THE RESULTS
Of our original population, 21,062 were available for
the survey, and we have completed investigations in 60%
of the subjects identified to have disease on the basis of
the questionnaire, blood pressure, or the presence of al-
bumin or glucose in the urine. The demographic char-
acteristics of this population are outlined in Tables 4 to
6. The sex ratio was 0.97, and the mean family size was
4.1. The literacy rate was 35% overall, 42% in males and
30% in females. Forty-three percent of the population
was economically dependent on the rest.
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Table 6. Employment status of the population by age and sex
Age groups Employment 0–15 16–65 65+ Total
Males
Unemployed/daily wage 3311 3117 89 6517
Skilled 3 443 42 488
Unskilled 7 2838 288 3133
Clerical 16 16
Professional 118 10 128
Shop owner 44 3 47
Others 13 10 23
Total 3334 6586 432 10,352
Females
Unemployed/daily wage 3228 6019 348 9595
Skilled 6 405 108 519
Unskilled 2 466 75 543
Clerical 7 7
Professional 12 2 14
Shop owner 2 1 3
Others 19 9 28
Total 3255 6920 534 10,709
Both sex
Unemployed/daily wage 6539 9136 437 16,111
Skilled 9 848 150 1007
Unskilled 9 3304 363 3676
Clerical 0 23 0 23
Professional 0 130 12 142
Shop owner 0 46 4 50
Others 32 19 0 51
Total 6589 13,506 966 21,060
Table 7. The findings of our first survey
Condition found Percentage of the population
Hypertension 5.26
Diabetes mellitus 3.64
Renal disease not in CRF 0.68
Urologic disease 0.26
Chronic renal failure 0.16
Needing our help 7.50
The total adds up to more than 7.50%, but many patients have more than one
condition.
The baseline characteristics as determined in our orig-
inal survey at the start of the program are listed in
Table 7. Of the new population of 21,496, we have sur-
veyed 15,232, and investigations have been done for 6100
residing in three villages. Details of the demographic data
have not been worked out for this population as yet, but it
is expected to be similar to the original population. GFR
has been calculated by the MDRD formula using age, sex,
urea, creatinine, and albumin, and the results for the two
groups have been compared. We have found the lower
limit of normal GFR in Indians to be 80 mL/min on the
basis of our unpublished observations on approximately
2000 live kidney donors at the Apollo Hospital, Chen-
nai. We found the number of people with GFR below
80 mL/min in the two groups, and compared them with
a chi-square test using Epi Info release 6 (CDC, Atlanta,
GA, USA).
GFR was found to be below 80 mL/min in the old area
in 8.6 per 1000 population, and in the new area in 13.9 per
1000 population (P = 0.005, relative risk 1.61, 95% confi-
dence interval 1.15–2.24). This suggests that our program
may have prevented or delayed the onset of renal failure
in 5.3 subjects per 1000 population.
DISCUSSION
I am aware that there are serious limitations to these
conclusions, and I present them here only as a very pre-
liminary report. Our goal was to study the entire popu-
lation. Results from the fraction we have studied cannot
legitimately be applied to the whole because it was not
a random sample. Economic circumstances could vary
from village to village, and the three we have completed
may not be representative of the whole. We may come to
a different conclusion on completion of the survey.
I have major worries. We will not be able to provide
treatment for the 8.6 per 1000 when they reach the end
stage. It will be no consolation to them to be told that
the areas not covered by the project had more patients,
and the concept that there is a significant reduction in
the disease burden may not be understandable to them.
If people get the feeling that we have not really helped
them, we may lose their cooperation, which is so vital to
the success of any such project.
Fifty thousand persons from a small corner of the coun-
try can never be representative of the 1 billion and more
of this vast land. However, there are many encouraging
aspects to it. The cost of 25 cents per capita is well within
the average of $7.40 per capita spent by the central and
state governments on health, and could easily be incorpo-
rated into the activities of the PHC. There may be other
benefits, which we have not specifically looked for, in pre-
vention of cerebral, coronary, and peripheral arterial dis-
ease, since control of hypertension has been excellent,
and control of diabetes fairly good. It has been relatively
easy to implement the program using unskilled workers
from the area, and provides them some supplemental in-
come with no need for relocation from their own homes.
CONCLUSION
I believe we have a model of prevention of chronic
renal failure well worth emulating in other parts of the
country, and of the world. It has been most gratifying to
find so many of our subjects staying with us and taking
their treatment regularly, and especially having people
from neighboring areas sufficiently impressed to request
us to include them in the program. I believe the reasons
for our success have been that we started with modest
and relatively simple goals, and especially the fact that
we established a domiciliary program which goes to the
villagers in their homes without waiting for them to seek
attention.
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